Bioceres Crop Solutions Receivables

The latest receivables for BIOX is $150M as of March 2026. That compares with $200M in the prior-year period — down 24.2% year over year. Investors often review this figure alongside Bioceres Crop Solutions's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOX's receivables moved from $200M to $150M — a 24.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bioceres Crop Solutions's operating scale or balance-sheet position.

A receivables figure of $150M for BIOX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BIOX's receivables ($150M), review year-over-year change from $200M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bioceres Crop Solutions's receivables against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.